Genipin relieves diabetic retinopathy by down-regulation of advanced glycation end products via the mitochondrial metabolism related signaling pathway

doi:10.4239/wjd.v14.i9.1349

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 9

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2966)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-7) series, Tables (1-2) series.

Item

Count

PDF

WORD

HTML

2019

Figures (1-7)

250

Tables (1-2)

172

Sum=2512

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

114

Download

176

Sum=290

Sep 15, 2023 (publication date) through Jun 29, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Diabetes. Sep 15, 2023; 14(9): 1349-1368
Published online Sep 15, 2023. doi: 10.4239/wjd.v14.i9.1349

Table 2 Features for signal, chain, modified residue, and glycosylation in SCG3

Type	Position	Description
Signal	1-19	-
Chain	20-468	Secretogranin-3
Modified residue	37	Phosphoserine
Glycosylation1	216	O-linked (GalNAcan) threonine
Glycosylation 2	231	O-linked (GalNAcan) threonine
Glycosylation 3	359	O-linked (GalNAcan) threonine
Modified residue	362	Phosphoserine

Citation: Sun KX, Chen YY, Li Z, Zheng SJ, Wan WJ, Ji Y, Hu K. Genipin relieves diabetic retinopathy by down-regulation of advanced glycation end products via the mitochondrial metabolism related signaling pathway. World J Diabetes 2023; 14(9): 1349-1368
URL: https://www.wjgnet.com/1948-9358/full/v14/i9/1349.htm
DOI: https://dx.doi.org/10.4239/wjd.v14.i9.1349